Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis
Authors
Keywords
Endometrial cancer, Metformin, Risk, Prognosis, Meta-analysis
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-18
DOI
10.1186/s12885-018-4334-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin, other antidiabetic drugs, and endometrial cancer risk
- (2017) Matteo Franchi et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
- (2017) Reetta Arima et al. GYNECOLOGIC ONCOLOGY
- Effects of metformin on endometrial cancer: Systematic review and meta-analysis
- (2017) Cinthia G. Meireles et al. GYNECOLOGIC ONCOLOGY
- Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus
- (2017) Faustino R. Perez-Lopez et al. MATURITAS
- Uterine Neoplasms, Version 1.2014
- (2017) Wui-Jin Koh et al. Journal of the National Comprehensive Cancer Network
- Measuring the biological effect of presurgical metformin treatment in endometrial cancer
- (2016) V N Sivalingam et al. BRITISH JOURNAL OF CANCER
- Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers
- (2016) Muhammad R. Khawaja et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The prognostic role of metformin in patients with endometrial cancer: a retrospective study
- (2016) Veronika Seebacher et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
- (2016) Mariam M. Al Hilli et al. GYNECOLOGIC ONCOLOGY
- Can Aspirin Reduce the Risk of Endometrial Cancer?
- (2016) Dongyu Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Use of Metformin in Obese Women With Type I Endometrial Cancer Is Associated With a Reduced Incidence of Cancer Recurrence
- (2016) Christopher Hall et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Statin Use Significantly Improves Overall Survival in High-Grade Endometrial Cancer
- (2016) Christine H. Feng et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Endometrial cancer
- (2016) Philippe Morice et al. LANCET
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Polycystic Ovary Syndrome
- (2016) Christopher R. McCartney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy
- (2016) Obiageli Ezewuiro et al. PLoS One
- Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors
- (2015) Rowan T. Chlebowski et al. CANCER
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015
- (2015) Yehuda Handelsman et al. Endocrine Practice
- Do endometrial cancer patients benefit from metformin intake?
- (2015) Agnieszka Lemańska et al. Ginekologia Polska
- Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan
- (2015) Chin-Hsiao Tseng GYNECOLOGIC ONCOLOGY
- Metformin and the risk of endometrial cancer: A population-based cohort study
- (2015) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women’s Health Initiative Randomized Trial
- (2015) R. T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women’s Health Initiative Randomized Trial
- (2015) R. T. Chlebowski et al. JNCI-Journal of the National Cancer Institute
- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Association between diabetes, diabetes treatment and risk of developing endometrial cancer
- (2014) J Luo et al. BRITISH JOURNAL OF CANCER
- Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
- (2014) Weiwei Shan et al. Journal of Gynecologic Oncology
- Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
- (2014) Kevin M. Schuler et al. Cancer Medicine
- Chemopreventive effects of metformin on obesity-associated endometrial proliferation
- (2013) Qian Zhang et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Metformin and the risk of endometrial cancer: A case–control analysis
- (2013) Claudia Becker et al. GYNECOLOGIC ONCOLOGY
- Metformin use and endometrial cancer survival
- (2013) Nicole S. Nevadunsky et al. GYNECOLOGIC ONCOLOGY
- Metformin is associated with improved survival in endometrial cancer
- (2013) Emily M. Ko et al. GYNECOLOGIC ONCOLOGY
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Insulin resistance: A significant risk factor of endometrial cancer
- (2012) Nan Mu et al. GYNECOLOGIC ONCOLOGY
- Prospective evaluation of insulin resistance among endometrial cancer patients
- (2011) Jennifer K. Burzawa et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Metabolic syndrome and endometrial cancer risk
- (2010) V. Rosato et al. ANNALS OF ONCOLOGY
- Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis
- (2010) Sílvia Cufí et al. CELL CYCLE
- Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
- (2010) Begoña Martin-Castillo et al. CELL CYCLE
- Reverse of Progestin-Resistant Atypical Endometrial Hyperplasia by Metformin and Oral Contraceptives
- (2010) Zong-Qi Shen et al. OBSTETRICS AND GYNECOLOGY
- Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: A post-hoc analysis of the BIGPRO1 trial
- (2009) A. Fontbonne et al. DIABETES & METABOLISM
- Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Siriwan Tangjitgamol et al. LANCET ONCOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started